ESC 365 - L-PGDS/ PGD2 is a regulator of cardiac metabolism during aging?

Open Access

L-PGDS/ PGD2 is a regulator of cardiac metabolism during aging?

Session: Pathophysiology and treatment

Topic: Cardiac Biology and Physiology

Speaker: Doctor L. Savchenko (Toulouse, FR)

Event: Heart Failure 2025

Congress Presentation

Add to my library

About the speaker

Doctor Lesia Savchenko

Institute of Cardiovascular and Metabolic Diseases, Toulouse (France)

0 follower

6 more presentations in this session

Inflamed atrial tissues of patients with atrial fibrillation are characterized by pro-oxidant and pro-remodeling responses: synergistic inhibition by an SGLT2 inhibitor plus a GLP-1R activation

Speaker: Doctor W. Fakih (Strasbourg, FR)

Mural cell dysfunction contributes to diastolic heart failure by promoting endothelial dysfunction and vessel remodeling

Speaker: Professor E. Jones (Leuven, BE)

Circulating low-grade inflammation in human pulmonary arterial hypertension promotes eNOS-NO/ROS imbalance: Involvement of the angiotensin and the endothelin pathways and prevention by EPA:DHA 6:1

Speaker: Ms H. MUZAMMEL (Strasbourg, FR)

Reversal of age-related diastolic dysfunction by micronized purified flavonoid fraction in rats with attenuation of low-grade inflammation, eNOS-NO/ROS imbalance, and left ventricular fibrosis

Speaker: Professor V. Schini-Kerth (Strasbourg, FR)

Effect of SGLT2i on myocardial remodeling due to cardiorenal syndrome in rat model of heart failure

Speaker: Doctor M. Sykora (Bratislava, SK)

Access the full session

Pathophysiology and treatment

Speakers: Doctor L. Savchenko, Doctor W. Fakih, Professor E. Jones, Ms H. MUZAMMEL, Professor V. Schini-Kerth...

About the event

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources